The reasons for the elevated adiponectin levels in persons with T1DM and for the paradoxical relationship between the known anti-atherogenic effects of adiponectin and premature mortality from coronary artery disease in T1DM are unclear. The gene discussed is ADIPOQ; the disease is coronary artery disorder.